background
Jill Durocher

Mifepristone's Multiple RH Indications: An overlooked Opportunity for Expanding Access

Published
September 23rd, 2019
Type
Program Brief
Topic
Medical Abortion
Authors
Gynuity Health Projects
Downloads

Gynuity Health Projects, with funds from the Reproductive Health Supplies Coalition (RHSC), developed an advocacy brief entitled “MIFEPRISTONE’S MULTIPLE RH INDICATIONS: AN OVERLOOKED OPPORTUNITY FOR EXPANDING ACCESS”. This brief provides the reasoning for why exploring alternative indications of mifepristone might be a good strategy to increase access and contains a literature review on four such indications: early pregnancy loss, intrauterine fetal death, second trimester abortion, and cervical preparation. It is available in English and Spanish.

Gynuity Health Projects, with funds from the Reproductive Health Supplies Coalition (RHSC), conducted a landscaping analysis to assess the global interest in alternative indications for mifepristone, geographic and market priorities for such an approach, and perceived barriers to pursuing registration for additional indications. We interviewed global social marketing organizations and manufacturers, as well as key stakeholders in six countries.